Showing results (171-180 of 190) with videos related to
Sort By:
Pageof 19
Breast Cancer Research and Treatment|May 1, 1997
Cytological evaluation of biological prognostic markers from primary breast carcinomasA Makris, D C Allred, T J Powles, et al.British Journal of Cancer|May 17, 2014
Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancerD K Woolf, M Beresford, S P Li, et al.Laboratory Animal Research|April 8, 2026
Endovascular coil embolization compared to surgical ligation of the uterine artery in a non-human primate model in a model of preeclampsiaA Makris, N Roshan, J Iliopoulos, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1997
Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomasA Makris, T J Powles, M Dowsett, et al.Annals of Surgical Oncology|August 12, 2020
A Novel Machine-Learning Approach to Predict Recurrence After Resection of Colorectal Liver MetastasesAnghela Z Paredes, J Madison Hyer, Diamantis I Tsilimigras, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 23, 2019
Response to preoperative chemotherapy: impact of change in total burden score and mutational tumor status on prognosis of patients undergoing resection for colorectal liver metastasesAndrea Ruzzenente, Fabio Bagante, Francesca Ratti, et al.British Journal of Cancer|October 13, 2011
Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase?R Leonard, R Ballinger, D Cameron, et al.British Journal of Cancer|August 25, 2011
Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT studyJ W F Catto, M C Robinson, P C Albertsen, et al.Breast Cancer Research and Treatment|June 29, 2010
DNA repair signature is associated with anthracycline response in triple negative breast cancer patientsA A Rodriguez, A Makris, M F Wu, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2007
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006M Kaufmann, G von Minckwitz, H D Bear, et al.Pageof 19